China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 18.85
+0.34 (1.84%)
At close: Mar 27, 2026
SHE:300294 Market Cap
SHE:300294 has a market cap or net worth of 9.51 billion as of March 27, 2026. Its market cap has decreased by -31.50% in one year.
Market Cap
9.51B
Enterprise Value
6.34B
Revenue
2.06B
Ranking
n/a
PE Ratio
85.68
Stock Price
18.85
Market Cap Chart
Since March 8, 2012, SHE:300294's market cap has increased from 2.94B to 9.51B, an increase of 223.19%. That is a compound annual growth rate of 8.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 9.51B | -16.59% |
| Dec 31, 2025 | 11.40B | -25.36% |
| Dec 31, 2024 | 15.27B | -10.10% |
| Dec 29, 2023 | 16.98B | -7.88% |
| Dec 30, 2022 | 18.44B | -4.67% |
| Dec 31, 2021 | 19.34B | 35.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.84B |
| InventisBio | 10.36B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| Liaoning Chengda Biotechnology | 10.03B |
| HitGen | 9.94B |
| Beijing Hotgen Biotech | 9.78B |
| Chongqing Genrix Biopharmaceutical | 9.57B |
| Bio-Thera Solutions | 9.23B |